31.74MMarket Cap-1325P/E (TTM)
22.500High17.820Low163.43KVolume18.000Open19.790Pre Close3.20MTurnover18.23%Turnover RatioLossP/E (Static)1.46MShares23.36452wk High3.39P/B19.46MFloat Cap4.11052wk Low--Dividend TTM896.39KShs Float6732.375Historical High--Div YieldTTM23.65%Amplitude4.110Historical Low19.557Avg Price1Lot Size
Forte Biosciences Stock Forum
News/update on their R&D on 3rd December 2024, Phase 1 top-line result by the second quarter of 2025. They have cash available which will sustain the company operations for 12 months (exclude the recent oversubscribed private placement 53mil)
https://www.etfdailynews.com/2024/11/18/forte-biosciences-nasdaqfbrx-price-target-raised-to-64-00/
No comment yet